We reported that the pathological acetylation profile of RelA and histones in brain ischemia can be corrected by the synergistic combination of low doses of the epigenetic drugs resveratrol and the HDAC inhibitor MS-275 (entinostat) (Lanzillotta et al., 2013). This evidence concerns the gene RELA and brain ischemia.